| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |